Skip to main content
SpringerLink
Log in

Cyclophosphamide (CTX) and high-dose 4-Epidoxorubicin (EPI) in advanced ovarian cancer (OC) treatment

  • Conference paper
Cancer Treatment An Update

  • 74 Accesses

Abstract

Cancer of the ovary is the fifth cause of cancer death in women, and the majority of patients have advanced stage disease at the time of presentation [1]. Clinical responses can be achieve with current regimens in over half of patients but only a minority enjoy prolonged disease free survival [2]. Consequently there is a need for innovative strategies to improve the prognosis in advanced stage patients. We have treated 52 consecutive patients, since September ‘87, with advanced ovarian cancer, utilizing a combination regimen based on the association between CTX and high-dose EPI-ADM in delayed administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Young RC, Fuks Z, Hoskins WJ (1989) Cancer of the ovary. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and practice of oncology. Lip-pincott, Philadelphia, pp. 1162–1196

    Google Scholar 

  2. Thigpen JT, Blessing JA, Vance RB et al (1989) Chemotherapy in ovarian carcinoma: present role and future prospectives. Sem Oncol 16: 58–65

    CAS  Google Scholar 

  3. Wheeler R, Ensminger WD, Thrall JH et al (1982) High-dose Doxorubicin: an exploration of the dose response curve in human neoplasia. Cancer Treat Rep 66: 493–498

    PubMed  CAS  Google Scholar 

  4. Omura G, Blessing JA, Ehrich CE (1986) A randomized trial of Cyclophosphamide and Doxorubicin with or without Cisplatin in advanced ovarian carcinoma. Cancer 57: 1725–1730

    Article  PubMed  CAS  Google Scholar 

  5. Hainsworth HD, Grosh WW, Burnett LS et al (1988) Advanced ovarian cancer: long terms results of treatment with intensive Cisplatin based chemotherapy of brief duration. Ann Inter Med 108: 115–170

    Article  Google Scholar 

  6. International federation of gynecology and obstetrics (1987) Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gyn 154: 236–237

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Med Oncology Dep, Gen Hospital Udine, Italy

    G. Cartei, M. Signor, E. Vigevani, M. Giovannoni, A. Sibau, G. Clocchiatti & M. Mansutti

Authors
  1. G. Cartei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Signor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Vigevani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Giovannoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Sibau
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Clocchiatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Mansutti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Saint-Louis, 1, avenue Vellefaux, 75475, Paris Cedex 10, France

    P. Banzet

  2. The Mount Sinai Medical Center, 1 G. Levy Place, New York, NY, 10029-6574, USA

    J. F. Holland

  3. Service d’Oncologie Médicale, Hôpital Pitié-Salpétrière Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    D. Khayat

  4. Hôpital Pitié-Salpétrière Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    M. Weil

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag France

About this paper

Cite this paper

Cartei, G. et al. (1994). Cyclophosphamide (CTX) and high-dose 4-Epidoxorubicin (EPI) in advanced ovarian cancer (OC) treatment. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_97

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0765-2_97

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0767-6

  • Online ISBN: 978-2-8178-0765-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation